Effectiveness of Percutaneous Intervention for Patients With Obstructive Hypertrophic Cardiomyopathy and Coronary Artery Disease - 21/08/11
Doi : 10.1016/j.amjcard.2005.04.023
Vijay Nambi, MD, John M. Buergler, MD, Nasser M. Lakkis, MD, Jennifer Franklin, RN, William H. Spencer, MD, Sherif F. Nagueh, MD ⁎ 
Section of Cardiology, Baylor College of Medicine, Methodist DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, Texas
Corresponding author: Tel.: 713-790-4495; fax: 713-793-1351.Résumé |
Seven patients with obstructive hypertrophic cardiomyopathy and single-vessel coronary artery disease underwent percutaneous revascularization of the coronary lesion in addition to alcohol septal ablation therapy for dynamic outflow tract obstruction. One year later, there was a significant reduction of dynamic left ventricular outflow tract obstruction and no clinical evidence of restenosis.
Le texte complet de cet article est disponible en PDF.© 2005
Elsevier Inc. Tous droits réservés.
Vol 96 - N° 4
P. 580-581 - août 2005 Retour au numéro
Article précédent
- Five-Year Follow-Up by Transesophageal Echocardiographic Studies in Primary Antiphospholipid Syndrome
- Maurizio Turiel, Piercarlo Sarzi-Puttini, Rossana Peretti, Sara Bonizzato, Sabrina Muzzupappa, Fabiola Atzeni, Edoardo Rossi, Andrea Doria
- Improving Outcomes in Fetuses and Neonates With Congenital Displacement (Ebstein’s Malformation) or Dysplasia of the Tricuspid Valve
- Doff B. McElhinney, Joshua W. Salvin, Steven D. Colan, Ravi Thiagarajan, Elizabeth C. Crawford, Edward N. Marcus, Pedro J. del Nido, Wayne Tworetzky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?